Specifically, increased IQGAP3 expression conferred DLBCL patients with PI3K-activated tumors exceptional long-term survival, and these patients actually fared as well as those in group A (Figure 5f–h). Here, PIK3CD is linked to diffuse large B-cell lymphoma.